Clinical Trial Update: Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating enarodustat for correcting anemia in adults with non-dialysis-dependent chronic kidney disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Enarodustat (enarodustat)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Chronic Kidney Disease Associated Anemia | Phase 4 | Status: RECRUITING